IL-17C is an important epithelial cell-derived cytokine activating innate immunity by the induction of antimicrobial peptides and cytokines. Here, we investigated the role of the cytosolic pattern recognition receptor nucleotide-binding oligomerization domain-containing protein 2 (NOD2) for the Staphylococcus aureusmediated induction of IL-17C. Activation of NOD2 in HEK293 cells overexpressing NOD2 induced the IL-17C promoter, an activity that was significantly reduced in cells overexpressing the Crohn's disease-associated NOD2 mutation 3020insC (1007fs) or the Crohn's disease-and atopic dermatitis-associated NOD2-R702W variant. The first NF-kB-binding site in the IL-17C promoter was critical for NOD2-mediated IL-17C induction. Infection of human primary keratinocytes with S. aureus induced NOD2 and IL-17C gene expression. Overexpression of NOD2 in keratinocytes augmented S. aureus-mediated IL-17C gene expression as compared with NOD2-R702W overexpression. S. aureus-induced IL-17C expression was diminished in NOD2 small interfering RNA (siRNA)treated keratinocytes. Moreover, significantly less S. aureus bacteria survived in keratinocytes overexpressing NOD2 but not in cells overexpressing the NOD2-R702W variant. Finally, S. aureus showed an increased survival in keratinocytes treated with NOD2 or IL-17C siRNA. In summary, our study provides evidence that S. aureus activates NOD2 in keratinocytes, resulting in an increased expression of IL-17C, a mechanism that may be dysregulated in atopic dermatitis.
INTRODUCTION
IL-17C is a cytokine that belongs to the IL-17 cytokine family consisting of six members: IL-17A, B, C, D, E, and IL-17F. IL-17 cytokines have an important role in regulating epithelial immune responses (Pappu et al., 2012) . The role of IL-17C is still not well defined. There is increasing evidence that IL-17C has an important role in epithelial antibacterial defense (Bordon, 2011) . Recently, it has been reported that IL-17C signals via a complex consisting of IL-17 receptor A and IL-17 receptor E and that IL-17C activates mucosal innate immunity by the induction of antimicrobial peptides and cytokines in the gut (Ramirez-Carrozzi et al., 2011; Song et al., 2011) . Similarly, IL-17C is expressed in keratinocytes and is able to induce several molecules associated with host defense and inflammation (Ramirez-Carrozzi et al., 2011) . Expression of IL-17C itself can be induced in keratinocytes by stimulation with bacterial products (peptidoglycan, flagellin) or cytokines such as tumor necrosis factor-a (Johansen et al., 2011; Ramirez-Carrozzi et al., 2011) . In addition, it has recently been reported that S. aureus induced IL-17C gene expression in a human skin equivalent model (Holland et al., 2009) .
S. aureus is one of the most relevant skin-associated pathogens that causes a broad spectrum of infections ranging from superficial skin infections to life-threatening systemic infections (Iwatsuki et al., 2006; Krishna and Miller, 2012) . It has been estimated that up to 30% of healthy individuals are colonized with S. aureus, providing a risk factor for subsequent infections (Krishna and Miller, 2012) . To initiate a fast defense reaction against S. aureus, keratinocytes must recognize the presence of S. aureus by pattern recognition receptors. Several studies indicate that Toll-like receptor 2 (TLR-2) is an important receptor in mediating an immune response to S. aureus by recognizing various components of S. aureus, including peptidoglycan and lipopeptides (Miller, 2008) . This was supported by in vivo studies demonstrating that TLR-2-deficient mice were highly susceptible to intravenous S. aureus infection (Takeuchi et al., 2000) . However, there are also data suggesting that TLR-2 is not essential for host defense against S. aureus skin infections, as subcutaneous inoculation of S. aureus in mice deficient in TLR-2 revealed only moderately larger lesions and minimally higher bacterial loads as compared with wild-type mice (Miller et al., 2006) . In addition, there is also some evidence that activation of keratinocytes by S. aureus is TLR-2 independent (Wanke et al., 2011) .
As it is known that S. aureus can be internalized by human keratinocytes (Kintarak et al., 2004) , one may speculate that keratinocytes use cytosolic receptors such as nucleotidebinding oligomerization domain-containing protein (NOD)like receptors for the intracellular recognition of S. aureus (Krishna and Miller, 2012) . The relevance of NOD2 in mediating immune responses to S. aureus has been demonstrated in NOD2-deficient mice, which developed larger skin ulcerations with impaired bacterial clearance compared with wild-type mice after subcutaneous infection with S. aureus (Hruz et al., 2009) . Moreover, it has been demonstrated that monomeric peptidoglycan fragments from S. aureus act as a natural agonist for NOD2 activation (Volz et al., 2010) .
A potential relevance of NOD2 in the skin is supported by studies revealing an association of polymorphisms in the NOD2 gene with atopic dermatitis (Kabesch et al., 2003; Macaluso et al., 2007) . Atopic dermatitis patients are more frequently colonized by S. aureus compared with healthy individuals, suggesting that the recognition of S. aureus might be impaired in AD patients (Ong, 2006) . However, the role of NOD2 to mediate recognition of S. aureus in human keratinocytes has not yet been examined, although it has been shown that NOD2 is functionally expressed in human keratinocytes (Voss et al., 2006) . Thus, the aim of this study was to assess the influence of NOD2 on the S. aureusmediated activation of keratinocytes, in particular on IL-17C induction by S. aureus.
RESULTS

NOD2 activates the IL-17C promoter
To analyze whether activation of NOD2 results in IL-17C promoter activation, HEK293 cells were transfected with an IL-17C luciferase promoter plasmid, co-transfected with a NOD2 expression plasmid, and stimulated with muramyl dipeptide (MDP) or the inactive stereoisomer MDP-LL. As shown in Figure 1 , activation of NOD2 by MDP resulted in an enhanced activation of the IL-17C promoter. In contrast, IL-17C promoter activation was significantly lower in cells overexpressing the NOD2-R702W variant and almost completely diminished in cells overexpressing the NOD2-3020insC variant (Figure 1 ).
The first NF-jB-binding site in the IL-17C promoter is required for NOD2-mediated IL-17C induction HEK293 cells transfected with a NOD2 expression plasmid and an IL-17C luciferase promoter plasmid containing three mutated NF-kB-binding sites showed an abolished IL-17C promoter activation upon MDP treatment as compared with the non-mutated IL-17C promoter (Figure 2a ). Analysis of separate NF-kB-binding site mutations revealed that only the first NF-kB-binding site is critical for NOD2-mediated IL-17C activation (Figure 2b ).
Induction of NOD2 and IL-17C expression in keratinocytes by S. aureus
To evaluate a possible role of NOD2 to mediate recognition of S. aureus in keratinocytes, we first infected keratinocytes with living S. aureus and analyzed NOD2 gene expression by real-time PCR. NOD2 gene expression was significantly upregulated by stimulation with living, but not with heat-inactivated, S. aureus, suggesting a potential function of NOD2 in keratinocytes upon S. aureus infection ( Figure 3a) . Similarly, living S. aureus, but not heat-inactivated S. aureus, induced IL-17C gene expression ( Figure 3b ), indicating that living S. aureus bacteria are required to induce IL-17C expression. Time-course experiments revealed induction of NOD2 ( Figure 3c ) and IL-17C ( Figure 3d ) already after 2 hours of treatment with living S. aureus.
Overexpression of NOD2 in keratinocytes enhances S. aureus-mediated IL-17C induction
To analyze the role of NOD2 for the S. aureus-mediated IL-17C expression in keratinocytes, we transiently overexpressed NOD2 or the NOD2-R702W variant in primary keratinocytes. Infection of NOD2-overexpressing keratinocytes with S. aureus resulted in an increased IL-17C gene induction as compared with keratinocytes transfected with an empty mock plasmid ( Figure 4a ). Furthermore, keratinocytes overexpressing the NOD2-R702W variant showed a significantly reduced IL-17C gene induction upon S. aureus treatment as compared with keratinocytes overexpressing wild-type NOD2 (Figure 4a ). Functional overexpression was verified by analysis of IL-8 gene expression, which showed a similar pattern as IL-17C ( Figure 4b ). NOD2 overexpression was also verified by real-time PCR, demonstrating always a NOD2 NOD2-R702W NOD2-3020insC Figure 1 . Activation of the IL-17C promoter through nucleotide-binding oligomerization domain-containing protein 2 (NOD2). HEK293 cells were co-transfected with an IL-17C firefly luciferase promoter plasmid and the phRG-TK Renilla luciferase plasmid for normalization and either the wild-type NOD2 expression plasmid or a NOD2-R702W expression plasmid or a NOD2-3020insC expression plasmid. Cells were cotreated with 1 mg of muramyl dipeptide (MDP) or MDP-LL (inactive isomer). IL-17C promoter activity was analyzed after 24 hours by measuring luciferase activity. Promoter activity was defined as the ratio between firefly and Renilla luciferase activities in each sample. Data are means ± SD of one representative experiment of two, each performed in triplicate (*Po0.05, Student's t-test).
strong increase of NOD2 gene expression (4200-fold) with no significant differences between cells transfected with the NOD2 wild-type or the NOD2 R702W variant plasmid (not shown).
siRNA-mediated downregulation of NOD2 in primary keratinocytes decreased S. aureus-mediated IL-17C induction
To further assess the influence of NOD2 on S. aureusmediated IL-17C induction, we used small interfering RNA (siRNA) to knockdown NOD2 expression in keratinocytes. Real-time PCR analyses revealed that transfection of keratinocytes with NOD2-specific siRNAs resulted always in a reduction of NOD2 gene expression of more than 75% as compared with the cells transfected with a non-silencing control siRNA (data not shown). Keratinocytes treated with a NOD2-specific siRNA showed a strongly reduced induction of IL-17C gene expression upon S. aureus treatment. Similar results were obtained using another NOD2-specific siRNA (Figure 5a ). To verify the gene expression data by an independent method and because we could not use an IL-17C ELISA owing to unspecific detection of S. aureus components (probably protein A), we used an IL-17C luciferase promoter assay to analyze the activation of IL-17C. Measurement of luciferase activity revealed that human primary keratinocytes treated with a NOD2-specific siRNA showed a reduced induction of the IL-17C promoter as compared with cells treated with a non-silencing control siRNA ( Figure 5b ). Taken together, these data confirm the involvement of NOD2 in the S. aureus-induced IL-17C expression in keratinocytes.
NOD2 and IL-17C contribute to the killing activity of keratinocytes against S. aureus Primary keratinocytes overexpressing NOD2 or the NOD2-R702W variant were infected with S. aureus and subsequently analyzed for the presence of viable S. aureus. Significantly less S. aureus survived in keratinocytes overexpressing NOD2 but not in cells overexpressing the NOD2-R702W variant (Figure 6a ). In support of these data, keratinocytes treated with a NOD2-specific siRNA were associated with higher S. aureus survival rates ( Figure 6b ). Keratinocytes treated with IL-17C-specific siRNA showed a moderate but significantly higher S. aureus survival ( Figure 6c ).
DISCUSSION
Our study demonstrates that activation of NOD2 by MDP activates IL-17C expression, as measured by activation of the IL-17C promoter. Mutational analyses revealed that the first NF-kB-binding site in the IL-17C promoter is a prerequisite for NOD2-mediated IL-17C expression similarly as reported for the tumor necrosis factor-a-induced expression of IL-17C (a) HEK293 cells were co-transfected with a NOD2 expression plasmid, the phRG-TK Renilla luciferase plasmid for normalization, and either with an IL-17C firefly luciferase promoter plasmid or an IL-17C luciferase promoter plasmid containing three mutated NF-kB-binding sites (NF-kB-mut1 þ 2 þ 3). Cells were cotreated with 1 mg of muramyl dipeptide (MDP) or the inactive isomer MDP-LL. IL-17C promoter activity was determined after 24 hours by measuring luciferase activity. Promoter activity was defined as the ratio between firefly and Renilla luciferase activities in each sample. (b) HEK293 cells were treated as in a but with three different plasmids each containing a separate mutated NF-kB-binding site. Data are means ± SD of triplicate stimulations. (Johansen et al., 2011) . This is in concordance with the known capability of NOD2 to activate NF-kB (Ogura et al., 2001; Franchi et al., 2008) , and it is in line with data showing that NOD2-mediated induction of the antimicrobial peptide human b-defensin-2 in keratinocytes requires NF-kB (Voss et al., 2006) .
Since the discovery of MDP as the bacterial ligand that initiates NOD2-dependent signaling, it is still a matter of debate whether NOD2 is able to directly bind to microbeassociated molecular patterns such as MDP. However, a recent study shed light on this issue. Grimes et al. (2012) reported that recombinantly produced NOD2 is able to bind to MDP, thus confirming that NOD2 indeed functions as an intracellular pattern recognition receptor that is able to bind MDP with high affinity (Grimes et al., 2012) .
The physiological role of NOD-like receptors in keratinocytes is poorly understood. Recently, Kobayashi et al. (2009) demonstrated that NOD2 gene expression is induced in human keratinocytes upon stimulation with various microbeassociated molecular patterns including peptidoglycan. Kobayashi et al. (2009) suggest that NOD2 might be an important molecule in keratinocytes, as all microbe-associated molecular patterns tested enhanced its expression. This conclusion is supported by this study that provides evidence that S. aureus stimulation significantly enhances NOD2 gene expression in primary keratinocytes, suggesting a potential role of NOD2 in the recognition of S. aureus in keratinocytes. Indeed, we could show that NOD2 has an important role in keratinocytes to mediate S. aureus-induced IL-17C expression. The rapid IL-17C gene induction after only 2 hours of stimulation with S. aureus suggests that the endogenous level of NOD2 in keratinocytes is high enough to enable an early response to S. aureus infection. The parallel induction of NOD2 during S. aureus infection may then promote further expression of IL-17C. Induction of IL-17C upon S. aureus infection may offer a rapid response to control the infection Interestingly, our data indicate that the NOD2-R702W variant, which was more frequent in atopic dermatitis patients than in controls (Macaluso et al., 2007) , displayed a diminished capability to induce IL-17C in keratinocytes infected with S. aureus. As the skin of atopic dermatitis patients is often characterized by increased S. aureus colonization and infection, it is possible that an impaired induction of IL-17C may promote S. aureus growth on the skin of atopic dermatitis patients. This is supported by our data demonstrating that keratinocytes treated with IL-17C-specific siRNA showed a weak, but significant, increased survival of S. aureus. However, to our knowledge, the expression level of IL-17C in atopic dermatitis has not yet been investigated. The impact of the NOD2-R702W variant on S. aureus colonization is further supported by our data showing that significantly less S. aureus bacteria were recovered from NOD2-overexpressing keratinocytes, but not from NOD2-R702W-overexpressing keratinocytes. This suggests that patients carrying such a mutation may have a reduced capability to fight off S. aureus, which fits well with the known high cutaneous S. aureus colonization rate in atopic dermatitis patients (Ong, 2006) .
In contrast to atopic dermatitis, skin infections of psoriasis patients with S. aureus and other bacteria are unexpectedly rare despite the disrupted skin surface (Henseler and Christophers, 1995) . Increased levels of innate defense molecules such as antimicrobial peptides have been implicated in the high infection resistance of psoriatic skin (Harder and Schröder, 2005) . Moreover, increased IL-17C gene expression has been detected in psoriatic skin (Johansen et al., 2009; Martin et al., 2012) . As IL-17C induces antimicrobial peptides and cytokines, increased levels of IL-17C may promote the expression of antimicrobial peptides and cytokines in psoriasis and may thereby trigger inflammation. This is supported by a mouse model in which IL-17C promoted inflammation in an imiquimod-induced skin-inflammation model (Ramirez-Carrozzi et al., 2011) . However, whether NOD2 may have a role in the IL-17C induction in psoriasis is not known and needs further investigation. In contrast to atopic dermatitis, psoriasis seems not to be associated with mutations in the NOD2 gene (Jenisch et al., 2006; Zhu et al., 2012) .
Several polymorphisms in the NOD2 gene have been initially described in patients with Crohn's disease, a chronic inflammatory bowel disease characterized by a disturbed intestinal epithelial barrier (Strober and Watanabe, 2011) . Our observation that NOD2 carrying the Crohn's diseaseassociated frameshift mutation 1007fs (3020InsC) almost completely lost its ability to induce IL-17C may be of relevance in intestinal innate immunity of Crohn's disease patients. As it has been reported that IL-17C may have an important role in epithelial defense of the gut (Song et al., 2011) , one might speculate that a diminished induction of IL-17C in Crohn's disease patients may impair mucosal defense, thereby augmenting uncontrolled bacterial growth leading to inflammation. As IL-17C is able to induce antimicrobial peptides, reduced levels of IL-17C may contribute to the reported induction defect of antimicrobial peptides in Crohn's disease (Wehkamp et al., 2003 (Wehkamp et al., , 2008 . However, this hypothesis remains to be proven.
Keratinocytes in which NOD2 expression was downregulated by siRNA still showed some IL-17C activation after S. aureus stimulation. It is likely that besides NOD2 other pattern recognition receptors participate in the recognition of S. aureus and subsequent IL-17C induction in keratinocytes. As mentioned in the introduction, there are some data providing evidence that TLR-2 can function as an important pattern recognition receptor in the case of S. aureus recognition, making it possible that IL-17C induction in keratinocytes by S. aureus also involves TLR-2 activation. This is supported by recent data showing that induction of IL-17C in HCT colon epithelial cells by peptidoglycan was diminished when the cells were treated with an anti-TLR-2 antibody (Ramirez-Carrozzi et al., 2011) . However, the exact role of TLR-2 in mediating S. aureus-induced IL-17C expression in keratinocytes remains to be shown.
In summary, we provide evidence that NOD2 mediates the recognition of S. aureus in keratinocytes, leading to enhanced IL-17C expression. Impaired recognition of S. aureus by intracellular receptors such as NOD2 may promote cutaneous colonization of S. aureus, as seen in atopic dermatitis. 
MATERIAL AND METHODS
Cell culture and stimulation
For stimulation experiments, primary human keratinocytes were cultured in collagen-coated 12-well plates in defined Epilife Medium (Life Technologies, Darmstadt, Germany) or Keratinocyte Growth Medium-2 (Promocell, Heidelberg, Germany) without antibiotics at 37 1C in a 5% CO 2 atmosphere. S. aureus bacteria (SH 1000) were grown in tryptic soy broth medium overnight at 37 1C, and then diluted and grown for an additional 2-3 hours until the OD 600 reached 0.2. Bacteria were harvested by centrifugation, washed with phosphate-buffered saline (PBS), and resuspended in the cell culture medium without antibiotics to an OD 600 of 0.2 corresponding to approx. 1.7 Â 10 7 colony-forming unit (CFU) ml À 1 . Confluent cells were stimulated with S. aureus at a concentration of approx. 5 Â 10 6 colony-forming units (CFU) per well. Bacteria were centrifuged on cells at 300g for 5 minutes, followed by incubation at 37 1C for 2 hours. Subsequently, the culture medium was removed and cells were washed two times with PBS containing 200 mg ml À 1 gentamicin to remove non-adherent bacteria. The cells were then incubated for an additional 4 hours in the culture medium supplemented with 200 mg ml À 1 gentamicin to kill any remaining extracellular bacteria.
In some experiments, bacteria were heat inactivated at 65 1C for 45 minutes before stimulation.
Plasmids used for transfection
To overexpress NOD2 and NOD2-3020InsC, expression plasmids containing the NOD2 cDNA cloned into the pEF6/V5 expression plasmid (Invitrogen, Darmstadt, Germany) were used (NOD2-pEF6/ V5-His and NOD2-3020InsC-pEF6/V5-His; Voss et al., 2006) . The NOD2 mutation R702W was inserted into the NOD2-pEF6/V5-His expression plasmid using site-directed mutagenesis, and the mutation was confirmed by sequencing. Verification of the functionality of the used plasmid is described in the Supplementary Figure S1 online. Activation of the IL-17C promoter was assessed by an IL-17C firefly luciferase promoter plasmid (hIL-17C-2-3204-luc2; Johansen et al., 2011) containing 3204 bp of the IL-17C promoter. To study the influence of NF-kB on IL-17C activation, the IL-17C luciferase promoter plasmid containing three mutated NF-kB-binding sites (NF-kB-mut1 þ 2 þ 3-luc2) or single mutated NF-kB-binding sites (NF-kB-mut1(2)(3)-luc2) were used (Johansen et al., 2011) .
Determination of NF-jB and IL-17C promoter activation
HEK293 cells were grown to 60-80% confluence in 12-well plates (BD Biosciences, San Jose, CA) and co-transfected using 1 ml of the transfection reagent TurboFect (Fermentas, St Leon-Rot, Germany) for 24 hours with 30 ng of either an empty pEF-6/V5-His plasmid (control) or the NOD2 overexpression plasmids and 75 ng of the indicated reporter plasmids and 10 ng of a Renilla luciferase expression plasmid (phRG-TK; Promega, Madison, WI), which served as an internal control. To activate NOD2, 1 mg of the synthetic NOD2 ligand MDP (Bachem, Bubendorf, Switzerland) or MDP-LL (inactive stereoisomer serving as a control) was added at the same time. After 24 hours, cells were harvested with 250 ml of passive lysis buffer (Promega), and firefly and Renilla luciferase activities were determined using the Dual Luciferase assay system (Promega) on a TD-20/20 luminometer (Turner Design, Sunnyvale, CA).
For the determination of IL-17C promoter activity in primary keratinocytes, cells were transfected at 70-90% confluence in 12-well plates with 0.5 mg of IL-17C firefly luciferase promoter plasmid and 0.05 mg of phRG-TK Renilla luciferase plasmid using 1 ml of transfection reagent Fugene6 (Promega). After 6 hours, the medium was replaced and cells were cultured for an additional 16-18 hours before stimulation with S. aureus. After stimulation, luciferase activity was analyzed as described above.
Overexpression of NOD2 in primary keratinocytes
Primary keratinocytes seeded in 12-well plates were transfected at 60-80% confluence. Before transfection, the culture medium was removed from cells and replaced with 450 ml of fresh medium. The cells were transfected with 500 ng of either an empty pEF-6/V5-His plasmid (control) or the NOD2 wild-type overexpression plasmid or the NOD2-R702W overexpression plasmid, respectively. The plasmid DNA and 2 ml of the transfection reagent Fugene6 (Promega) were diluted in 50 ml of the culture medium and incubated at room temperature for 15 minutes before addition to the cells. At 6 hours after transfection, the transfection medium was replaced with fresh medium and stimulation was carried out after an additional 24 hours.
siRNA-mediated knockdown of NOD2 expression
Two NOD2-specific and an IL-17C-specific SilencerSelect siRNAs (s34483, s34485, s25972) and a non-silencing control siRNA (4390844) were purchased from Life Technologies. Primary keratinocytes were cultured in 12-well plates and transfected with 10 nM siRNA at 30-50% confluence using 2 ml of transfection reagent HiPerFect (Qiagen, Hilden, Germany). After 16-20 hours, siRNA was removed and cells were further cultured for 2-3 days until they reached 100% confluence for stimulation with S. aureus.
Real-time PCR
After stimulation, cells were lysed using the RNA isolation reagent RNAmagic (Biolab Products, Gödenstorf, Germany), and total RNA was isolated according to the manufacturer's protocol. cDNA was synthesized from 1 mg of total isolated RNA by 50 U of Maxima Reverse Transcriptase (Fermentas, St Leon-Rot, Germany) using oligo dT primer. cDNA corresponding to 10 ng of total RNA served as template in a real-time PCR, which was performed in a StepOne Real-Time PCR System (Applied Biosystem, Carlsbad, CA) using 5.2 ml of SYBR Premix Ex Taq II (TaKaRa Bio, Saint-Germain-en-Laye, France) in a 10-ml reaction volume and 0.4 ml of 10 mM sense and antisense primer. Amplifications were carried out with the following temperature profiles: after an initial denaturation step for 30 seconds at 95 1C, the elongation temperature was lowered by 1 1C per cycle from 66 1C to 60 1C for six cycles, followed by 40 cycles with an elongation temperature of 60 1C. Each cycle comprised 5 seconds of denaturation at 95 1C and 30 seconds at elongation temperature. To confirm amplification specificity, a melting curve was generated at the end of the run by gradually heating from 60 to 95 1C and monitoring SYBR Green I signal intensities. Standard curves were generated for each primer set with serial dilutions of cDNA. The housekeeping gene human acidic ribosomal protein was used as a reference to normalize gene expression data. Relative expression is given as a ratio between target gene expression and human acidic ribosomal protein expression. The following intron-spanning primers were used: IL-17C, 5 0 -GAGGTGTTGGAGGCAGACA-3 0 (forward primer) and 5 0 -CA TCGATACAGCCTCTGCAC-3 0 (reverse primer); NOD2, 5 0 -GATGAA ATCAGGTTGCCGAT-3 0 (forward primer) and 5 0 -TAGAAGGAAGGC AGCCAATC-3 0 (reverse primer); and human acidic ribosomal protein, 5 0 -CACCATTGAAATCCTGAGTGATGT-3 0 (forward primer) and 5 0 -TGACCAGCCCAAAGGAGAAG-3 0 (reverse primer).
Antimicrobial assays
To investigate the influence of NOD2 and IL-17C on the killing activity of keratinocytes against S. aureus, we incubated the siRNAtreated or NOD2-overexpressing keratinocytes with S. aureus for 6 hours as described above. Afterward, the culture supernatant was removed, the cells were washed two times with PBS, and then harvested in 300 ml of 0.1% Triton X-100 in PBS. After sonication, the lysates were diluted with PBS and plated in different dilutions on trypticase-soy agar plates. Colonies were counted after overnight incubation at 37 1C.
